DexCom Operating Income Over Time
| DXCM Stock | USD 73.16 0.07 0.1% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out DexCom Performance and DexCom Correlation. Will Health Care Equipment & Supplies sector continue expanding? Could DexCom diversify its offerings? Factors like these will boost the valuation of DexCom. Projected growth potential of DexCom fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every DexCom data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.78 | Earnings Share 2.09 | Revenue Per Share | Quarterly Revenue Growth 0.131 | Return On Assets |
Understanding DexCom Inc requires distinguishing between market price and book value, where the latter reflects DexCom's accounting equity. The concept of intrinsic value - what DexCom's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push DexCom's price substantially above or below its fundamental value.
It's important to distinguish between DexCom's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DexCom should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, DexCom's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Operating Income Analysis
Compare DexCom Inc and related stocks such as STERIS plc, Insulet, and Zimmer Biomet Holdings Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STE | 200 K | 222.3 M | 242.8 M | 206.8 M | 227.2 M | 212.9 M | 226.2 M | 399.9 M | 411 M | 537 M | 548.4 M | 477.8 M | 791.1 M | 836.1 M | 866.6 M | 996.6 M | 1 B |
| PODD | (12.7 M) | (42.5 M) | (36 M) | (29.1 M) | (12.3 M) | (48.7 M) | (10.7 M) | (7.4 M) | 27.4 M | 50 M | 51.5 M | 126 M | 37.6 M | 220 M | 308.9 M | 473.8 M | 497.5 M |
| ZBH | 211 M | 1 B | 1 B | 1 B | 1 B | 467.3 M | 821.1 M | 799.3 M | 33.8 M | 1.1 B | 83.1 M | 860.3 M | 696.3 M | 1.3 B | 1.3 B | 1.4 B | 861 M |
| PHG | 868.3 M | (269 M) | 1 B | 2 B | 486 M | 992 M | 1.9 B | 1.5 B | 1.7 B | 1.4 B | 1.3 B | 553 M | (1.5 B) | (115 M) | 529 M | 1.4 B | 850.1 M |
| SNN | 127.9 M | 862 M | 846 M | 810 M | 749 M | 628 M | 801 M | 934 M | 863 M | 815 M | 295 M | 593 M | 315 M | 425 M | 657 M | 755.5 M | 500.2 M |
| LH | 313.9 M | 948.4 M | 1 B | 990.9 M | 910.4 M | 1 B | 1.3 B | 1.4 B | 1.3 B | 1.3 B | 2.4 B | 3 B | 1.4 B | 725.6 M | 1.1 B | 1.5 B | 836.4 M |
| WAT | 56.4 M | 528.6 M | 511.5 M | 517.3 M | 517.9 M | 567.5 M | 625 M | 662.2 M | 739.8 M | 708.5 M | 645.5 M | 821.7 M | 873.4 M | 817.7 M | 826.4 M | 893.2 M | 495.2 M |
| BIIB | (32.9 M) | 1.7 B | 1.8 B | 2.5 B | 4 B | 4.9 B | 5.2 B | 5.3 B | 5.9 B | 7 B | 4.6 B | 2.8 B | 2.9 B | 2.1 B | 2.5 B | 1.9 B | 1.6 B |
| WST | 23.5 M | 115.9 M | 136.5 M | 162.4 M | 182 M | 128.6 M | 196.8 M | 228.9 M | 254.8 M | 297.2 M | 419 M | 758.7 M | 763.5 M | 710.9 M | 594.6 M | 617.4 M | 648.3 M |
| TEVA | 11.9 M | 3.1 B | 2.2 B | 1.6 B | 4 B | 3.4 B | 2.2 B | (17.5 B) | (1.6 B) | (443 M) | (3.6 B) | 1.7 B | (2.2 B) | 433 M | (303 M) | 2.2 B | 2.3 B |
DexCom Inc and related stocks such as STERIS plc, Insulet, and Zimmer Biomet Holdings Operating Income description
Operating Income is the amount of profit realized from DexCom Inc operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of DexCom Inc is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| DexCom Inc | DXCM |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 6340 Sequence Drive, |
| Exchange | NASDAQ Exchange |
USD 73.16
Check out DexCom Performance and DexCom Correlation. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
DexCom technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.